56. Turning cancer on itself, Sam Mazin, Founder and CTO, Thorsten Melcher, CBO, RefleXion
Samuel Mazin, Ph.D. Founder and Chief Technology Officer Member, Board of Directors Sam Mazin, Ph.D., co-founded RefleXion Medical in 2009, where he is the inventor of the company’s core technology. ...
28 Huhti 202127min
55. Gene therapy for hearing loss, Heather Wolff, VP of Clinical Development Operations, Decibel
Heather Wolff joined Decibel in February 2018 as the head of clinical development operations for Decibel Therapeutics. Heather is responsible for Decibel’s clinical operations, regulatory operations, ...
21 Huhti 202121min
54. CRISPR treating cancer, Rachel Haurwitz, Co-founder and CEO, Caribou Biosciences
Rachel is a co-founder of Caribou Biosciences and has been President and CEO since its inception in 2011. Rachel is an inventor on several patents and patent applications covering multiple CRISPR-base...
14 Huhti 202122min
53. Leading a rare disease biopharma company, Paula Ragan, CEO and President, X4 Pharmaceuticals
Dr. Ragan has been X4’s President and Chief Executive Officer and a member of the X4 Board of Directors since July 2014. She has more than 18 years of experience building companies in the biotechnolog...
8 Huhti 202127min
52. SPACs and infectious disease past and future, Joe Hernandez, CEO, Blue Water Acquisition Corp.
Joseph Hernandez is an established leader in biotech entrepreneurship and early-stage technology development. With a strong background in biology, epidemiology, molecular genetics, marketing, and fina...
31 Maalis 202122min
51. Pioneering innovations for neurological indications, Chris Wright, CMO, Cyclerion
Chief Medical Officer, Christopher Wright, MD, PhD, is a neurologist and neuroscientist who brings two decades of medical research and drug development experience in orphan and specialty diseases, inc...
25 Maalis 202127min
50. Noninvasive diagnostics for NASH and inflammatory indications, Caroline Loew, CEO, Glympse Bio
Caroline is a biopharmaceutical executive with over 20 years of experience successfully leading diverse, empowered, and integrated teams. She has broad experience integrating science, business, and th...
17 Maalis 202127min
49. Restoring connections for neurodegenerative diseases, Leen Kawas, CEO, Athira Pharma
Leen Kawas, Ph.D., has served as our chief executive officer and as a member of our board of directors since January 2014. Previously, Dr. Kawas served as our vice president. Dr. Kawas serves on multi...
10 Maalis 202118min
